Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model

In vivo reprogramming of astrocytes to dopamine neurons improves motor behavior in a mouse model of Parkinson's disease. Cell replacement therapies for neurodegenerative disease have focused on transplantation of the cell types affected by the pathological process. Here we describe an alternati...

Full description

Saved in:
Bibliographic Details
Published in:Nature biotechnology Vol. 35; no. 5; pp. 444 - 452
Main Authors: Rivetti di Val Cervo, Pia, Romanov, Roman A, Spigolon, Giada, Masini, Débora, Martín-Montañez, Elisa, Toledo, Enrique M, La Manno, Gioele, Feyder, Michael, Pifl, Christian, Ng, Yi-Han, Sánchez, Sara Padrell, Linnarsson, Sten, Wernig, Marius, Harkany, Tibor, Fisone, Gilberto, Arenas, Ernest
Format: Journal Article
Language:English
Published: New York Springer New York 01.05.2017
Nature Publishing Group
Subjects:
ISSN:1087-0156, 1546-1696, 1546-1696
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract In vivo reprogramming of astrocytes to dopamine neurons improves motor behavior in a mouse model of Parkinson's disease. Cell replacement therapies for neurodegenerative disease have focused on transplantation of the cell types affected by the pathological process. Here we describe an alternative strategy for Parkinson's disease in which dopamine neurons are generated by direct conversion of astrocytes. Using three transcription factors, NEUROD1, ASCL1 and LMX1A, and the microRNA miR218, collectively designated NeAL218, we reprogram human astrocytes in vitro , and mouse astrocytes in vivo , into induced dopamine neurons (iDANs). Reprogramming efficiency in vitro is improved by small molecules that promote chromatin remodeling and activate the TGFβ, Shh and Wnt signaling pathways. The reprogramming efficiency of human astrocytes reaches up to 16%, resulting in iDANs with appropriate midbrain markers and excitability. In a mouse model of Parkinson's disease, NeAL218 alone reprograms adult striatal astrocytes into iDANs that are excitable and correct some aspects of motor behavior in vivo , including gait impairments. With further optimization, this approach may enable clinical therapies for Parkinson's disease by delivery of genes rather than cells.
AbstractList Cell replacement therapies for neurodegenerative disease have focused on transplantation of the cell types affected by the pathological process. Here we describe an alternative strategy for Parkinson's disease in which dopamine neurons are generated by direct conversion of astrocytes. Using three transcription factors, NEUROD1, ASCL1 and LMX1A, and the microRNA miR218, collectively designated NeAL218, we reprogram human astrocytes in vitro, and mouse astrocytes in vivo, into induced dopamine neurons (iDANs). Reprogramming efficiency in vitro is improved by small molecules that promote chromatin remodeling and activate the TGFβ, Shh and Wnt signaling pathways. The reprogramming efficiency of human astrocytes reaches up to 16%, resulting in iDANs with appropriate midbrain markers and excitability. In a mouse model of Parkinson's disease, NeAL218 alone reprograms adult striatal astrocytes into iDANs that are excitable and correct some aspects of motor behavior in vivo, including gait impairments. With further optimization, this approach may enable clinical therapies for Parkinson's disease by delivery of genes rather than cells.Cell replacement therapies for neurodegenerative disease have focused on transplantation of the cell types affected by the pathological process. Here we describe an alternative strategy for Parkinson's disease in which dopamine neurons are generated by direct conversion of astrocytes. Using three transcription factors, NEUROD1, ASCL1 and LMX1A, and the microRNA miR218, collectively designated NeAL218, we reprogram human astrocytes in vitro, and mouse astrocytes in vivo, into induced dopamine neurons (iDANs). Reprogramming efficiency in vitro is improved by small molecules that promote chromatin remodeling and activate the TGFβ, Shh and Wnt signaling pathways. The reprogramming efficiency of human astrocytes reaches up to 16%, resulting in iDANs with appropriate midbrain markers and excitability. In a mouse model of Parkinson's disease, NeAL218 alone reprograms adult striatal astrocytes into iDANs that are excitable and correct some aspects of motor behavior in vivo, including gait impairments. With further optimization, this approach may enable clinical therapies for Parkinson's disease by delivery of genes rather than cells.
Cell replacement therapies for neurodegenerative disease have focused on transplantation of the cell types affected by the pathological process. Here we describe an alternative strategy for Parkinson's disease in which dopamine neurons are generated by direct conversion of astrocytes. Using three transcription factors, NEUROD1, ASCL1 and LMX1A, and the microRNA miR218, collectively designated NeAL218, we reprogram human astrocytes in vitro, and mouse astrocytes in vivo, into induced dopamine neurons (iDANs). Reprogramming efficiency in vitro is improved by small molecules that promote chromatin remodeling and activate the TGFβ, Shh and Wnt signaling pathways. The reprogramming efficiency of human astrocytes reaches up to 16%, resulting in iDANs with appropriate midbrain markers and excitability. In a mouse model of Parkinson's disease, NeAL218 alone reprograms adult striatal astrocytes into iDANs that are excitable and correct some aspects of motor behavior in vivo, including gait impairments. With further optimization, this approach may enable clinical therapies for Parkinson's disease by delivery of genes rather than cells.
Cell replacement therapies for neurodegenerative disease have focused on transplantation of the cell types affected by the pathological process. Here we describe an alternative strategy for Parkinson's disease in which dopamine neurons are generated by direct conversion of astrocytes. Using three transcription factors, NEUROD1, ASCL1 and LMX1A, and the microRNA miR218, collectively designated NeAL218, we reprogram human astrocytes in vitro, and mouse astrocytes in vivo, into induced dopamine neurons (iDANs). Reprogramming efficiency in vitro is improved by small molecules that promote chromatin remodeling and activate the TGF beta , Shh and Wnt signaling pathways. The reprogramming efficiency of human astrocytes reaches up to 16%, resulting in iDANs with appropriate midbrain markers and excitability. In a mouse model of Parkinson's disease, NeAL218 alone reprograms adult striatal astrocytes into iDANs that are excitable and correct some aspects of motor behavior in vivo, including gait impairments. With further optimization, this approach may enable clinical therapies for Parkinson's disease by delivery of genes rather than cells.
In vivo reprogramming of astrocytes to dopamine neurons improves motor behavior in a mouse model of Parkinson's disease. Cell replacement therapies for neurodegenerative disease have focused on transplantation of the cell types affected by the pathological process. Here we describe an alternative strategy for Parkinson's disease in which dopamine neurons are generated by direct conversion of astrocytes. Using three transcription factors, NEUROD1, ASCL1 and LMX1A, and the microRNA miR218, collectively designated NeAL218, we reprogram human astrocytes in vitro , and mouse astrocytes in vivo , into induced dopamine neurons (iDANs). Reprogramming efficiency in vitro is improved by small molecules that promote chromatin remodeling and activate the TGFβ, Shh and Wnt signaling pathways. The reprogramming efficiency of human astrocytes reaches up to 16%, resulting in iDANs with appropriate midbrain markers and excitability. In a mouse model of Parkinson's disease, NeAL218 alone reprograms adult striatal astrocytes into iDANs that are excitable and correct some aspects of motor behavior in vivo , including gait impairments. With further optimization, this approach may enable clinical therapies for Parkinson's disease by delivery of genes rather than cells.
In vivo reprogramming of astrocytes to dopamine neurons improves motor behavior in a mouse model of Parkinson's disease.Cell replacement therapies for neurodegenerative disease have focused on transplantation of the cell types affected by the pathological process. Here we describe an alternative strategy for Parkinson's disease in which dopamine neurons are generated by direct conversion of astrocytes. Using three transcription factors, NEUROD1, ASCL1 and LMX1A, and the microRNA miR218, collectively designated NeAL218, we reprogram human astrocytes in vitro, and mouse astrocytes in vivo, into induced dopamine neurons (iDANs). Reprogramming efficiency in vitro is improved by small molecules that promote chromatin remodeling and activate the TGFβ, Shh and Wnt signaling pathways. The reprogramming efficiency of human astrocytes reaches up to 16%, resulting in iDANs with appropriate midbrain markers and excitability. In a mouse model of Parkinson's disease, NeAL218 alone reprograms adult striatal astrocytes into iDANs that are excitable and correct some aspects of motor behavior in vivo, including gait impairments. With further optimization, this approach may enable clinical therapies for Parkinson's disease by delivery of genes rather than cells.
Audience Academic
Author Harkany, Tibor
Wernig, Marius
Rivetti di Val Cervo, Pia
Ng, Yi-Han
Masini, Débora
Martín-Montañez, Elisa
Feyder, Michael
Pifl, Christian
Arenas, Ernest
Spigolon, Giada
Romanov, Roman A
Toledo, Enrique M
Linnarsson, Sten
La Manno, Gioele
Sánchez, Sara Padrell
Fisone, Gilberto
Author_xml – sequence: 1
  givenname: Pia
  surname: Rivetti di Val Cervo
  fullname: Rivetti di Val Cervo, Pia
  organization: Department of Medical Biochemistry and Biophysics, Laboratory of Molecular Neurobiology, Karolinska Institutet
– sequence: 2
  givenname: Roman A
  surname: Romanov
  fullname: Romanov, Roman A
  organization: Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Department of Neuroscience, Karolinska Institutet
– sequence: 3
  givenname: Giada
  surname: Spigolon
  fullname: Spigolon, Giada
  organization: Department of Neuroscience, Karolinska Institutet
– sequence: 4
  givenname: Débora
  surname: Masini
  fullname: Masini, Débora
  organization: Department of Neuroscience, Karolinska Institutet
– sequence: 5
  givenname: Elisa
  surname: Martín-Montañez
  fullname: Martín-Montañez, Elisa
  organization: Department of Medical Biochemistry and Biophysics, Laboratory of Molecular Neurobiology, Karolinska Institutet, Department of Pharmacology, Faculty of Medicine, Biomedical Research Institute of Malaga (IBIMA), Malaga University
– sequence: 6
  givenname: Enrique M
  orcidid: 0000-0002-1460-4708
  surname: Toledo
  fullname: Toledo, Enrique M
  organization: Department of Medical Biochemistry and Biophysics, Laboratory of Molecular Neurobiology, Karolinska Institutet
– sequence: 7
  givenname: Gioele
  surname: La Manno
  fullname: La Manno, Gioele
  organization: Department of Medical Biochemistry and Biophysics, Laboratory of Molecular Neurobiology, Karolinska Institutet
– sequence: 8
  givenname: Michael
  orcidid: 0000-0001-5849-905X
  surname: Feyder
  fullname: Feyder, Michael
  organization: Department of Neuroscience, Karolinska Institutet
– sequence: 9
  givenname: Christian
  surname: Pifl
  fullname: Pifl, Christian
  organization: Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna
– sequence: 10
  givenname: Yi-Han
  surname: Ng
  fullname: Ng, Yi-Han
  organization: Institute for Stem Cell Biology and Regenerative Medicine, Stanford University
– sequence: 11
  givenname: Sara Padrell
  surname: Sánchez
  fullname: Sánchez, Sara Padrell
  organization: Department of Medical Biochemistry and Biophysics, Laboratory of Molecular Neurobiology, Karolinska Institutet
– sequence: 12
  givenname: Sten
  surname: Linnarsson
  fullname: Linnarsson, Sten
  organization: Department of Medical Biochemistry and Biophysics, Laboratory of Molecular Neurobiology, Karolinska Institutet
– sequence: 13
  givenname: Marius
  surname: Wernig
  fullname: Wernig, Marius
  organization: Institute for Stem Cell Biology and Regenerative Medicine, Stanford University
– sequence: 14
  givenname: Tibor
  surname: Harkany
  fullname: Harkany, Tibor
  organization: Department of Molecular Neurosciences, Center for Brain Research, Medical University of Vienna, Department of Neuroscience, Karolinska Institutet
– sequence: 15
  givenname: Gilberto
  surname: Fisone
  fullname: Fisone, Gilberto
  organization: Department of Neuroscience, Karolinska Institutet
– sequence: 16
  givenname: Ernest
  orcidid: 0000-0003-0197-6577
  surname: Arenas
  fullname: Arenas, Ernest
  email: ernest.arenas@ki.se
  organization: Department of Medical Biochemistry and Biophysics, Laboratory of Molecular Neurobiology, Karolinska Institutet
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28398344$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:135777783$$DView record from Swedish Publication Index (Karolinska Institutet)
BookMark eNqNk21r2zAQx83oWB822CcYgr1YB3MmWbIsvyxlD4FCx57eCtk6pWptKZXsrWVffkqTJU0oowis8_l3J99fd4fZnvMOsuwlwROCqXjvmmFCBS2fZAekZDwnvOZ7ycaiyjEp-X52GOMlxpgzzp9l-4WgtaCMHWR_pk6P7WC9Q94gM7o7W3VI-7nqrQPkYAzeRWSC79HF2CuHVByCb28HiMg69MumN6ScRr0fI-x8VeiLClfWRe_eRKRtBJWY3mvonmdPjeoivFjtR9mPjx--n37Oz84_TU9PzvK2InzIWZuqAaWZqIjitFJEs0YZrjFvSl20gKHk0FSmqIgwFRjNC8axMoxDaypMj7J8mTf-hvnYyHmwvQq30isrV66rZIFkdcUpS_zxkp8Hfz1CHGRvYwtdpxykCiWpMal40vYRqBC8Kgnli794vYNe-jEkqaOkRcEppWXxX4qImguGhSg31Ex1IK0zfgiqXRwtT1hNaMHru1yTB6i0NPS2TR1kbPJvBbzdCkjMADfDTI0xyum3r49nz39us-_usc0YU1_F9Ih2djHEZcgW_mqlwdj0oNf39a9rN6q3wccYwKwRguViIGQaCLkYiI0Ga7S1g1r0eNLCdg8FrOqKKaebQbh3AbvsX-uKGCU
CitedBy_id crossref_primary_10_1242_dev_177188
crossref_primary_10_3390_cells8080826
crossref_primary_10_1016_j_neuron_2021_11_023
crossref_primary_10_1089_cell_2022_0065
crossref_primary_10_3390_cells6030026
crossref_primary_10_1038_s41467_023_39552_9
crossref_primary_10_3390_cells6030024
crossref_primary_10_1038_s41531_019_0105_5
crossref_primary_10_1016_j_ymthe_2021_01_001
crossref_primary_10_1038_s41419_021_03498_x
crossref_primary_10_3390_cells14120905
crossref_primary_10_15252_emmm_202114797
crossref_primary_10_4103_1673_5374_386400
crossref_primary_10_1038_s41598_022_12404_0
crossref_primary_10_1002_mds_27067
crossref_primary_10_3390_biomedicines10102598
crossref_primary_10_1016_j_bcp_2017_07_003
crossref_primary_10_1371_journal_pone_0261730
crossref_primary_10_3389_fnagi_2020_00024
crossref_primary_10_3390_diseases8040042
crossref_primary_10_59675_M2022_03
crossref_primary_10_1016_j_phrs_2020_105190
crossref_primary_10_3389_fnmol_2021_556215
crossref_primary_10_1016_j_neuroscience_2019_03_042
crossref_primary_10_1111_nyas_15004
crossref_primary_10_3390_ijms232113043
crossref_primary_10_3390_ijms22179608
crossref_primary_10_3390_ijms24108614
crossref_primary_10_1038_nbt_3869
crossref_primary_10_1016_j_seizure_2020_11_022
crossref_primary_10_3390_antiox13080999
crossref_primary_10_3389_fnagi_2021_738529
crossref_primary_10_1016_j_neulet_2020_135010
crossref_primary_10_1002_stem_3300
crossref_primary_10_1186_s40659_024_00534_w
crossref_primary_10_1039_D1SC03069H
crossref_primary_10_3389_fnagi_2021_689276
crossref_primary_10_3390_cells12040618
crossref_primary_10_1016_j_nsa_2024_104061
crossref_primary_10_1016_j_neuron_2019_08_009
crossref_primary_10_3389_fnmol_2021_642016
crossref_primary_10_1038_d41586_020_01817_4
crossref_primary_10_1038_s41593_025_01981_8
crossref_primary_10_1016_j_stemcr_2025_102600
crossref_primary_10_3389_fncel_2020_00107
crossref_primary_10_1016_j_molmed_2020_08_006
crossref_primary_10_4103_1673_5374_221147
crossref_primary_10_1089_cell_2025_0008
crossref_primary_10_3390_cells10020253
crossref_primary_10_1016_j_neuron_2025_03_036
crossref_primary_10_1098_rsob_210289
crossref_primary_10_1016_j_heares_2019_107859
crossref_primary_10_3390_ph15070811
crossref_primary_10_1002_1873_3468_13678
crossref_primary_10_3390_cells10082019
crossref_primary_10_3389_fcell_2020_00809
crossref_primary_10_1007_s12264_022_00829_6
crossref_primary_10_3390_jdb7010003
crossref_primary_10_3390_ijms21218060
crossref_primary_10_12688_f1000research_18926_1
crossref_primary_10_3390_ijms232213936
crossref_primary_10_1016_j_chaos_2024_115154
crossref_primary_10_3389_fcell_2022_927555
crossref_primary_10_1007_s40259_018_0294_1
crossref_primary_10_1016_j_bcp_2017_06_129
crossref_primary_10_3389_fncel_2021_682597
crossref_primary_10_1016_j_jconrel_2018_07_017
crossref_primary_10_3389_fgeed_2021_644319
crossref_primary_10_1007_s12035_022_03173_y
crossref_primary_10_3390_cells12040528
crossref_primary_10_1002_adma_202003800
crossref_primary_10_1038_s41467_022_33584_3
crossref_primary_10_1146_annurev_genet_120417_031534
crossref_primary_10_1016_j_biopha_2021_112273
crossref_primary_10_3390_biom10091269
crossref_primary_10_4103_1673_5374_265185
crossref_primary_10_3389_fcell_2018_00016
crossref_primary_10_3389_fnagi_2022_885707
crossref_primary_10_1038_s41593_020_00736_x
crossref_primary_10_3390_ijms23136961
crossref_primary_10_1177_1073858421992265
crossref_primary_10_3390_ijerph19148799
crossref_primary_10_1016_j_bbrc_2021_11_040
crossref_primary_10_1007_s12975_025_01331_7
crossref_primary_10_1002_dneu_22951
crossref_primary_10_3390_biomedicines10040928
crossref_primary_10_1038_nrneurol_2017_60
crossref_primary_10_3390_biomedicines12030663
crossref_primary_10_3390_ijms23020845
crossref_primary_10_1111_apha_13967
crossref_primary_10_1016_j_stem_2017_06_011
crossref_primary_10_3390_ijms23052557
crossref_primary_10_4103_1673_5374_325747
crossref_primary_10_3389_fnagi_2022_1069482
crossref_primary_10_1161_CIRCRESAHA_117_311866
crossref_primary_10_3389_fcell_2021_665795
crossref_primary_10_1186_s12967_024_04881_w
crossref_primary_10_1007_s12264_021_00751_3
crossref_primary_10_3389_fncel_2022_858432
crossref_primary_10_1016_j_arr_2025_102808
crossref_primary_10_1155_2021_6669787
crossref_primary_10_5194_pb_4_185_2017
crossref_primary_10_1007_s10072_023_07175_z
crossref_primary_10_1016_j_molmed_2019_06_006
crossref_primary_10_1016_j_tibtech_2024_07_012
crossref_primary_10_1242_dev_200128
crossref_primary_10_3390_cells11060940
crossref_primary_10_1016_j_cell_2020_03_024
crossref_primary_10_1016_j_pneurobio_2018_12_007
crossref_primary_10_1002_SMMD_20220005
crossref_primary_10_1016_j_jgg_2019_10_003
crossref_primary_10_1515_jpm_2022_0575
crossref_primary_10_3389_fncel_2020_00058
crossref_primary_10_1002_glia_24361
crossref_primary_10_1016_j_ejphar_2024_176930
crossref_primary_10_1096_fj_202501157R
crossref_primary_10_1016_j_neuron_2025_08_009
crossref_primary_10_1038_s41398_019_0573_8
crossref_primary_10_3389_fcell_2021_681087
crossref_primary_10_1016_j_mcn_2024_103947
crossref_primary_10_1016_j_expneurol_2024_114817
crossref_primary_10_1042_BSR20231717
crossref_primary_10_1002_adtp_202300040
crossref_primary_10_4103_NRR_NRR_D_24_01062
crossref_primary_10_3389_fcell_2020_590008
crossref_primary_10_1007_s00018_019_03193_3
crossref_primary_10_1038_s41419_018_0891_4
crossref_primary_10_1016_j_prp_2024_155641
crossref_primary_10_4103_1673_5374_270292
crossref_primary_10_1016_j_stem_2021_09_002
crossref_primary_10_3389_fcell_2021_648020
crossref_primary_10_3389_fncel_2023_1237641
crossref_primary_10_1002_mds_28306
crossref_primary_10_4103_1673_5374_390976
crossref_primary_10_3390_ijms21113995
crossref_primary_10_1002_ibra_12189
crossref_primary_10_3390_ijms222212141
crossref_primary_10_1038_nnano_2017_133
crossref_primary_10_4103_1673_5374_295925
crossref_primary_10_1016_j_conb_2017_10_025
crossref_primary_10_1038_s41421_021_00243_8
crossref_primary_10_3390_brainsci13030524
crossref_primary_10_1111_jcmm_15616
crossref_primary_10_1186_s40035_021_00265_y
crossref_primary_10_3389_fped_2018_00082
crossref_primary_10_1177_0271678X20910324
crossref_primary_10_4103_1673_5374_390965
crossref_primary_10_1242_dev_200433
crossref_primary_10_1007_s11684_021_0900_3
crossref_primary_10_1038_s41598_019_47482_0
crossref_primary_10_1016_j_ydbio_2023_10_006
crossref_primary_10_1016_j_ymthe_2019_09_003
crossref_primary_10_1515_tnsci_2020_0004
crossref_primary_10_1146_annurev_genet_071719_023616
crossref_primary_10_1038_s41586_020_2388_4
crossref_primary_10_1016_j_gde_2021_06_002
crossref_primary_10_3389_fcell_2020_00116
crossref_primary_10_1124_pharmrev_122_000801
crossref_primary_10_1007_s13311_020_00947_x
crossref_primary_10_1002_dneu_22882
crossref_primary_10_3389_fmicb_2022_875101
crossref_primary_10_1016_j_conb_2021_03_014
crossref_primary_10_1016_j_expneurol_2018_08_010
crossref_primary_10_3389_fncel_2020_594170
crossref_primary_10_3389_fnins_2022_917071
crossref_primary_10_1002_dneu_22880
crossref_primary_10_1089_scd_2019_0208
crossref_primary_10_3389_fbioe_2021_658498
crossref_primary_10_1089_scd_2021_0363
crossref_primary_10_1038_s41536_017_0033_0
crossref_primary_10_3389_fbioe_2022_799152
crossref_primary_10_3390_nano13101680
crossref_primary_10_1002_ame2_12545
crossref_primary_10_1002_dvdy_24655
crossref_primary_10_1134_S1062360422040026
crossref_primary_10_1007_s11064_019_02781_w
crossref_primary_10_1038_s41551_022_00963_6
crossref_primary_10_3390_brainsci12091175
crossref_primary_10_1016_j_expneurol_2023_114571
crossref_primary_10_1016_j_neuropharm_2024_110217
crossref_primary_10_3389_fnmol_2018_00077
crossref_primary_10_3389_fnagi_2018_00109
crossref_primary_10_3390_ijms24065665
crossref_primary_10_1016_j_brainres_2018_03_013
crossref_primary_10_1242_dev_204459
crossref_primary_10_3389_fcell_2020_00760
crossref_primary_10_3389_fnins_2022_894620
crossref_primary_10_1101_cshperspect_a041611
crossref_primary_10_3389_fncel_2020_00121
crossref_primary_10_1038_s41586_018_0087_1
crossref_primary_10_1007_s00441_017_2729_2
crossref_primary_10_3389_fcell_2019_00082
crossref_primary_10_1038_s41419_023_05737_9
crossref_primary_10_1016_j_bbrc_2019_10_118
crossref_primary_10_1016_j_biopha_2024_116806
crossref_primary_10_3389_fnins_2018_00800
crossref_primary_10_1016_j_pneurobio_2018_04_005
crossref_primary_10_1038_s41598_022_04833_8
crossref_primary_10_1089_scd_2019_0189
crossref_primary_10_1093_sleep_zsaa173
crossref_primary_10_1016_j_pharmr_2025_100077
crossref_primary_10_3390_ijms232314753
crossref_primary_10_1002_stem_3315
crossref_primary_10_3389_fnagi_2020_571185
crossref_primary_10_1016_j_nbd_2023_106224
crossref_primary_10_1038_s41598_021_01366_4
crossref_primary_10_3390_ph16101359
crossref_primary_10_3390_cells12091253
crossref_primary_10_3389_fnagi_2021_612856
crossref_primary_10_1159_000511083
crossref_primary_10_3390_ijms21124273
crossref_primary_10_3389_fncel_2022_903469
crossref_primary_10_1007_s13311_020_00940_4
crossref_primary_10_3389_fnagi_2019_00334
crossref_primary_10_3390_jfb10030032
crossref_primary_10_3389_fncel_2023_1328269
crossref_primary_10_1016_j_jchemneu_2023_102286
crossref_primary_10_31083_j_jin2002055
crossref_primary_10_3389_fnagi_2023_1174341
crossref_primary_10_3389_fnins_2019_00131
crossref_primary_10_17816_morph_637000
crossref_primary_10_1111_ejn_15742
crossref_primary_10_1002_jnr_24922
crossref_primary_10_4103_1673_5374_353482
crossref_primary_10_1002_wrna_1674
crossref_primary_10_1134_S0026893321040087
crossref_primary_10_1038_s41467_020_14855_3
crossref_primary_10_1097_01_NT_0000696124_35386_d9
crossref_primary_10_7554_eLife_75636
crossref_primary_10_1016_j_neurol_2019_11_002
crossref_primary_10_1016_j_isci_2023_108130
Cites_doi 10.1111/j.1749-6632.1987.tb23695.x
10.1101/cshperspect.a009258
10.1186/s13059-014-0550-8
10.1016/j.cell.2006.07.024
10.1038/nature10648
10.1016/j.stemcr.2014.10.007
10.3389/fnbeh.2014.00290
10.1038/ncomms10652
10.1126/science.aaa1934
10.1038/cr.2011.181
10.1371/journal.pone.0028719
10.1038/nrn2652
10.1523/JNEUROSCI.1358-06.2006
10.1242/dev.097394
10.1038/nprot.2010.188
10.1073/pnas.1220637110
10.1242/dev.127.19.4203
10.1038/nature10202
10.1016/j.stem.2011.09.011
10.1016/j.stem.2015.12.003
10.1038/nn828
10.1038/ncb2765
10.1073/pnas.1105135108
10.1016/j.bbr.2015.03.058
10.1016/j.neulet.2007.09.060
10.1016/j.cell.2016.09.027
10.1111/j.1460-9568.2008.06040.x
10.1016/j.bbrc.2010.04.037
10.1016/j.celrep.2015.06.040
10.1073/pnas.1303829110
10.1016/j.nbd.2004.01.007
10.1038/nature08797
10.1016/j.mcn.2004.08.004
10.1016/j.stem.2013.12.001
10.1038/nbt1418
10.1021/cb400259n
10.1038/nbt.1529
10.1371/journal.pbio.1000373
10.1016/j.stem.2009.12.001
10.1016/j.stem.2008.01.004
10.1073/pnas.0605208103
10.1002/jnr.10395
10.1038/nrneurol.2014.252
10.1007/s004410050990
10.1093/jmcb/mjq008
10.1002/stem.493
10.1016/S0140-6736(88)90950-6
10.1038/nature10284
10.1038/nrm3543
10.1111/j.1460-9568.2011.07873.x
10.1186/1743-0003-2-20
10.1523/ENEURO.0106-15.2015
10.1038/ncomms4338
10.1016/j.diff.2015.10.002
ContentType Journal Article
Copyright Springer Nature America, Inc. 2017
COPYRIGHT 2017 Nature Publishing Group
Copyright Nature Publishing Group May 2017
Springer Nature America, Inc. 2017.
Copyright_xml – notice: Springer Nature America, Inc. 2017
– notice: COPYRIGHT 2017 Nature Publishing Group
– notice: Copyright Nature Publishing Group May 2017
– notice: Springer Nature America, Inc. 2017.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
N95
IOV
ISR
3V.
7QO
7QP
7QR
7T7
7TK
7TM
7X7
7XB
88A
88E
88I
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
8G5
ABJCF
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
GUQSH
HCIFZ
K9.
L6V
LK8
M0S
M1P
M2O
M2P
M7P
M7S
MBDVC
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PTHSS
Q9U
RC3
PRINS
7X8
ADTPV
AOWAS
D8T
ZZAVC
DOI 10.1038/nbt.3835
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale Business: Insights
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Biotechnology Research Abstracts
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Neurosciences Abstracts
Nucleic Acids Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Technology collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Research Library
Science Database (subscription)
Biological Science Database
Engineering Database
Research Library (Corporate)
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
Engineering Collection
ProQuest Central Basic
Genetics Abstracts
ProQuest Central China
MEDLINE - Academic
SwePub
SwePub Articles
SWEPUB Freely available online
SwePub Articles full text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
ProQuest Central Basic
ProQuest Science Journals
ProQuest SciTech Collection
ProQuest Medical Library
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest Central China
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Research Library Prep
Neurosciences Abstracts

MEDLINE

Research Library Prep
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Engineering
Agriculture
Biology
EISSN 1546-1696
EndPage 452
ExternalDocumentID oai_swepub_ki_se_497634
4322270041
A491326920
28398344
10_1038_nbt_3835
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Sweden
GeographicLocations_xml – name: Sweden
GroupedDBID ---
-~X
.55
.GJ
0R~
123
29M
2FS
2XV
36B
39C
4.4
4R4
53G
5BI
5M7
5RE
5S5
70F
7X7
88E
88I
8AO
8CJ
8FE
8FG
8FH
8FI
8FJ
8G5
8R4
8R5
A8Z
AAHBH
AAIKC
AAMNW
AARCD
AAYOK
AAYZH
ABAWZ
ABDBF
ABDPE
ABEFU
ABJCF
ABJNI
ABLJU
ABOCM
ABUWG
ACBTR
ACBWK
ACGFO
ACGFS
ACGOD
ACIWK
ACMJI
ACPRK
ACUHS
ADBBV
ADFRT
AENEX
AEUYN
AFANA
AFBBN
AFFNX
AFKRA
AFRAH
AFSHS
AGAYW
AHBCP
AHMBA
AHOSX
AHSBF
AIBTJ
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALPWD
AMTXH
ARMCB
ASPBG
AVWKF
AXYYD
AZFZN
AZQEC
BAAKF
BBNVY
BENPR
BGLVJ
BHPHI
BKKNO
BKOMP
BPHCQ
BVXVI
C0K
CCPQU
D1J
DB5
DU5
DWQXO
EAD
EAP
EAS
EBC
EBS
EE.
EJD
EMB
EMK
EMOBN
ESX
EXGXG
F5P
FA8
FEDTE
FQGFK
FSGXE
FYUFA
GNUQQ
GUQSH
GX1
HCIFZ
HMCUK
HVGLF
HZ~
IAG
IAO
IEA
IEP
IH2
IHR
INH
INR
IOV
ISR
ITC
KOO
L6V
LGEZI
LK8
LOTEE
M1P
M2O
M2P
M7P
M7S
ML0
MVM
N95
NADUK
NEJ
NFIDA
NNMJJ
NXXTH
O9-
ODYON
P2P
PHGZT
PQQKQ
PROAC
PSQYO
PTHSS
Q2X
QF4
QM4
QN7
QO4
RNS
RNT
RNTTT
RVV
RXW
SHXYY
SIXXV
SJN
SNYQT
SOJ
SV3
TAE
TAOOD
TBHMF
TDRGL
TN5
TSG
TUS
U5U
UKHRP
X7M
XOL
Y6R
YZZ
ZGI
ZHY
ZXP
~KM
AAYXX
ACSTC
AFFHD
AGSTI
ATHPR
CITATION
PHGZM
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QO
7QP
7QR
7T7
7TK
7TM
7XB
88A
8FD
8FK
C1K
FR3
K9.
MBDVC
P64
PKEHL
PQEST
PQUKI
Q9U
RC3
PRINS
7X8
PUEGO
ABFSG
ADTPV
AEZWR
AFHIU
AHWEU
AIXLP
AOWAS
D8T
ZZAVC
ID FETCH-LOGICAL-c716t-4c696ead4871a637a1d4baf6d06b5d2ce0e56eb7f2718f7efd62460af46ecf703
IEDL.DBID M2P
ISICitedReferencesCount 265
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000400809800019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1087-0156
1546-1696
IngestDate Tue Nov 25 03:27:39 EST 2025
Sun Nov 09 13:51:33 EST 2025
Thu Oct 02 16:37:47 EDT 2025
Sat Nov 29 14:26:23 EST 2025
Tue Oct 07 05:20:01 EDT 2025
Tue Nov 11 10:06:10 EST 2025
Tue Nov 04 18:00:59 EST 2025
Thu Nov 13 15:49:07 EST 2025
Thu Nov 13 15:50:39 EST 2025
Sat Nov 29 08:38:32 EST 2025
Thu Apr 03 07:26:13 EDT 2025
Sat Nov 29 08:01:49 EST 2025
Tue Nov 18 22:25:24 EST 2025
Wed Apr 23 01:20:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c716t-4c696ead4871a637a1d4baf6d06b5d2ce0e56eb7f2718f7efd62460af46ecf703
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-0197-6577
0000-0002-1460-4708
0000-0001-5849-905X
OpenAccessLink http://kipublications.ki.se/Default.aspx?queryparsed=id:135777783
PMID 28398344
PQID 1896840885
PQPubID 47191
PageCount 9
ParticipantIDs swepub_primary_oai_swepub_ki_se_497634
proquest_miscellaneous_1901760874
proquest_miscellaneous_1886751360
proquest_journals_3226333520
proquest_journals_1896840885
gale_infotracmisc_A491326920
gale_infotracacademiconefile_A491326920
gale_incontextgauss_ISR_A491326920
gale_incontextgauss_IOV_A491326920
gale_businessinsightsgauss_A491326920
pubmed_primary_28398344
crossref_primary_10_1038_nbt_3835
crossref_citationtrail_10_1038_nbt_3835
springer_journals_10_1038_nbt_3835
PublicationCentury 2000
PublicationDate 2017-05-01
PublicationDateYYYYMMDD 2017-05-01
PublicationDate_xml – month: 05
  year: 2017
  text: 2017-05-01
  day: 01
PublicationDecade 2010
PublicationPlace New York
PublicationPlace_xml – name: New York
– name: United States
PublicationSubtitle The Science and Business of Biotechnology
PublicationTitle Nature biotechnology
PublicationTitleAbbrev Nat Biotechnol
PublicationTitleAlternate Nat Biotechnol
PublicationYear 2017
Publisher Springer New York
Nature Publishing Group
Publisher_xml – name: Springer New York
– name: Nature Publishing Group
References K Takahashi (BFnbt3835_CR6) 2006; 126
G La Manno (BFnbt3835_CR35) 2016; 167
O Lindvall (BFnbt3835_CR3) 1988; 2
C Heinrich (BFnbt3835_CR16) 2010; 8
I Amende (BFnbt3835_CR49) 2005; 2
MJ Kurz (BFnbt3835_CR47) 2007; 429
O Torper (BFnbt3835_CR22) 2015; 12
Z Guo (BFnbt3835_CR20) 2014; 14
MI Ekstrand (BFnbt3835_CR55) 2007; 104
T Brambrink (BFnbt3835_CR24) 2008; 2
G DeMaagd (BFnbt3835_CR1) 2015; 40
TL Chung (BFnbt3835_CR33) 2010; 28
S Darmopil (BFnbt3835_CR40) 2008; 27
A Zeisel (BFnbt3835_CR52) 2015; 347
Z Su (BFnbt3835_CR19) 2014; 5
M Lundblad (BFnbt3835_CR39) 2004; 16
S Jhas (BFnbt3835_CR37) 2006; 26
C Heinrich (BFnbt3835_CR21) 2014; 3
E Arenas (BFnbt3835_CR5) 2015; 142
J Kim (BFnbt3835_CR11) 2011; 9
DW Dickson (BFnbt3835_CR51) 2012; 2
G Hu (BFnbt3835_CR42) 2013; 8
MI Love (BFnbt3835_CR53) 2014; 15
S Gascón (BFnbt3835_CR23) 2016; 18
A Fasano (BFnbt3835_CR46) 2015; 11
E Arenas (BFnbt3835_CR4) 2010; 396
U Pfisterer (BFnbt3835_CR13) 2011; 108
SP Brooks (BFnbt3835_CR44) 2009; 10
J Ladewig (BFnbt3835_CR8) 2013; 14
MA Esteban (BFnbt3835_CR25) 2010; 6
N Koyano-Nakagawa (BFnbt3835_CR36) 2000; 127
T Vierbuchen (BFnbt3835_CR7) 2010; 463
D Huangfu (BFnbt3835_CR31) 2008; 26
M Caiazzo (BFnbt3835_CR10) 2011; 476
A Bonito-Oliva (BFnbt3835_CR48) 2014; 8
Z Freyberg (BFnbt3835_CR43) 2016; 7
M Wernig (BFnbt3835_CR27) 2002; 69
O Torper (BFnbt3835_CR18) 2013; 110
M Masuda (BFnbt3835_CR41) 2011; 34
C Heinrich (BFnbt3835_CR17) 2011; 6
V Bagga (BFnbt3835_CR45) 2015; 288
N Heins (BFnbt3835_CR15) 2002; 5
T Huang (BFnbt3835_CR30) 2010; 2
X Liu (BFnbt3835_CR34) 2013; 15
X Liu (BFnbt3835_CR12) 2012; 22
O Dillon-Carter (BFnbt3835_CR38) 1998; 291
SM Chambers (BFnbt3835_CR26) 2009; 27
H Wang (BFnbt3835_CR50) 2015; 90
J Wang (BFnbt3835_CR54) 2004; 27
P Brundin (BFnbt3835_CR2) 1987; 495
G Chen (BFnbt3835_CR9) 2015; 2
ZP Pang (BFnbt3835_CR29) 2011; 476
RC Addis (BFnbt3835_CR14) 2011; 6
S Kriks (BFnbt3835_CR28) 2011; 480
G Pennarossa (BFnbt3835_CR32) 2013; 110
28590561 - Mov Disord. 2017 Jul;32(7):991
28486448 - Nat Biotechnol. 2017 May 9;35(5):426-428
28429802 - Nat Rev Neurol. 2017 Jun;13(6):318-319
References_xml – volume: 495
  start-page: 473
  year: 1987
  ident: BFnbt3835_CR2
  publication-title: Ann. NY Acad. Sci.
  doi: 10.1111/j.1749-6632.1987.tb23695.x
– volume: 2
  start-page: a009258
  year: 2012
  ident: BFnbt3835_CR51
  publication-title: Cold Spring Harb. Perspect. Med.
  doi: 10.1101/cshperspect.a009258
– volume: 15
  start-page: 550
  year: 2014
  ident: BFnbt3835_CR53
  publication-title: Genome Biol.
  doi: 10.1186/s13059-014-0550-8
– volume: 126
  start-page: 663
  year: 2006
  ident: BFnbt3835_CR6
  publication-title: Cell
  doi: 10.1016/j.cell.2006.07.024
– volume: 480
  start-page: 547
  year: 2011
  ident: BFnbt3835_CR28
  publication-title: Nature
  doi: 10.1038/nature10648
– volume: 3
  start-page: 1000
  year: 2014
  ident: BFnbt3835_CR21
  publication-title: Stem Cell Reports
  doi: 10.1016/j.stemcr.2014.10.007
– volume: 8
  start-page: 290
  year: 2014
  ident: BFnbt3835_CR48
  publication-title: Front. Behav. Neurosci.
  doi: 10.3389/fnbeh.2014.00290
– volume: 7
  start-page: 10652
  year: 2016
  ident: BFnbt3835_CR43
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms10652
– volume: 347
  start-page: 1138
  year: 2015
  ident: BFnbt3835_CR52
  publication-title: Science
  doi: 10.1126/science.aaa1934
– volume: 22
  start-page: 321
  year: 2012
  ident: BFnbt3835_CR12
  publication-title: Cell Res.
  doi: 10.1038/cr.2011.181
– volume: 6
  start-page: e28719
  year: 2011
  ident: BFnbt3835_CR14
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0028719
– volume: 10
  start-page: 519
  year: 2009
  ident: BFnbt3835_CR44
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn2652
– volume: 26
  start-page: 11061
  year: 2006
  ident: BFnbt3835_CR37
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1358-06.2006
– volume: 142
  start-page: 1918
  year: 2015
  ident: BFnbt3835_CR5
  publication-title: Development
  doi: 10.1242/dev.097394
– volume: 6
  start-page: 214
  year: 2011
  ident: BFnbt3835_CR17
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2010.188
– volume: 110
  start-page: 8948
  year: 2013
  ident: BFnbt3835_CR32
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1220637110
– volume: 127
  start-page: 4203
  year: 2000
  ident: BFnbt3835_CR36
  publication-title: Development
  doi: 10.1242/dev.127.19.4203
– volume: 476
  start-page: 220
  year: 2011
  ident: BFnbt3835_CR29
  publication-title: Nature
  doi: 10.1038/nature10202
– volume: 9
  start-page: 413
  year: 2011
  ident: BFnbt3835_CR11
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2011.09.011
– volume: 18
  start-page: 396
  year: 2016
  ident: BFnbt3835_CR23
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2015.12.003
– volume: 5
  start-page: 308
  year: 2002
  ident: BFnbt3835_CR15
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn828
– volume: 15
  start-page: 829
  year: 2013
  ident: BFnbt3835_CR34
  publication-title: Nat. Cell Biol.
  doi: 10.1038/ncb2765
– volume: 108
  start-page: 10343
  year: 2011
  ident: BFnbt3835_CR13
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1105135108
– volume: 288
  start-page: 107
  year: 2015
  ident: BFnbt3835_CR45
  publication-title: Behav. Brain Res.
  doi: 10.1016/j.bbr.2015.03.058
– volume: 429
  start-page: 39
  year: 2007
  ident: BFnbt3835_CR47
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2007.09.060
– volume: 167
  start-page: 566
  year: 2016
  ident: BFnbt3835_CR35
  publication-title: Cell
  doi: 10.1016/j.cell.2016.09.027
– volume: 40
  start-page: 591
  year: 2015
  ident: BFnbt3835_CR1
  publication-title: P&T
– volume: 27
  start-page: 580
  year: 2008
  ident: BFnbt3835_CR40
  publication-title: Eur. J. Neurosci.
  doi: 10.1111/j.1460-9568.2008.06040.x
– volume: 396
  start-page: 152
  year: 2010
  ident: BFnbt3835_CR4
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2010.04.037
– volume: 12
  start-page: 474
  year: 2015
  ident: BFnbt3835_CR22
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2015.06.040
– volume: 110
  start-page: 7038
  year: 2013
  ident: BFnbt3835_CR18
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.1303829110
– volume: 16
  start-page: 110
  year: 2004
  ident: BFnbt3835_CR39
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2004.01.007
– volume: 463
  start-page: 1035
  year: 2010
  ident: BFnbt3835_CR7
  publication-title: Nature
  doi: 10.1038/nature08797
– volume: 27
  start-page: 489
  year: 2004
  ident: BFnbt3835_CR54
  publication-title: Mol. Cell. Neurosci.
  doi: 10.1016/j.mcn.2004.08.004
– volume: 14
  start-page: 188
  year: 2014
  ident: BFnbt3835_CR20
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2013.12.001
– volume: 26
  start-page: 795
  year: 2008
  ident: BFnbt3835_CR31
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt1418
– volume: 8
  start-page: 1947
  year: 2013
  ident: BFnbt3835_CR42
  publication-title: ACS Chem. Biol.
  doi: 10.1021/cb400259n
– volume: 27
  start-page: 275
  year: 2009
  ident: BFnbt3835_CR26
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.1529
– volume: 8
  start-page: e1000373
  year: 2010
  ident: BFnbt3835_CR16
  publication-title: PLoS Biol.
  doi: 10.1371/journal.pbio.1000373
– volume: 6
  start-page: 71
  year: 2010
  ident: BFnbt3835_CR25
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2009.12.001
– volume: 2
  start-page: 151
  year: 2008
  ident: BFnbt3835_CR24
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2008.01.004
– volume: 104
  start-page: 1325
  year: 2007
  ident: BFnbt3835_CR55
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0605208103
– volume: 69
  start-page: 918
  year: 2002
  ident: BFnbt3835_CR27
  publication-title: J. Neurosci. Res.
  doi: 10.1002/jnr.10395
– volume: 11
  start-page: 98
  year: 2015
  ident: BFnbt3835_CR46
  publication-title: Nat. Rev. Neurol.
  doi: 10.1038/nrneurol.2014.252
– volume: 291
  start-page: 191
  year: 1998
  ident: BFnbt3835_CR38
  publication-title: Cell Tissue Res.
  doi: 10.1007/s004410050990
– volume: 2
  start-page: 152
  year: 2010
  ident: BFnbt3835_CR30
  publication-title: J. Mol. Cell Biol.
  doi: 10.1093/jmcb/mjq008
– volume: 28
  start-page: 1848
  year: 2010
  ident: BFnbt3835_CR33
  publication-title: Stem Cells
  doi: 10.1002/stem.493
– volume: 2
  start-page: 1483
  year: 1988
  ident: BFnbt3835_CR3
  publication-title: Lancet
  doi: 10.1016/S0140-6736(88)90950-6
– volume: 476
  start-page: 224
  year: 2011
  ident: BFnbt3835_CR10
  publication-title: Nature
  doi: 10.1038/nature10284
– volume: 14
  start-page: 225
  year: 2013
  ident: BFnbt3835_CR8
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm3543
– volume: 34
  start-page: 1355
  year: 2011
  ident: BFnbt3835_CR41
  publication-title: Eur. J. Neurosci.
  doi: 10.1111/j.1460-9568.2011.07873.x
– volume: 2
  start-page: 20
  year: 2005
  ident: BFnbt3835_CR49
  publication-title: J. Neuroeng. Rehabil.
  doi: 10.1186/1743-0003-2-20
– volume: 2
  start-page: e0106
  year: 2015
  ident: BFnbt3835_CR9
  publication-title: eNeuro.
  doi: 10.1523/ENEURO.0106-15.2015
– volume: 5
  start-page: 3338
  year: 2014
  ident: BFnbt3835_CR19
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms4338
– volume: 90
  start-page: 69
  year: 2015
  ident: BFnbt3835_CR50
  publication-title: Differentiation
  doi: 10.1016/j.diff.2015.10.002
– reference: 28486448 - Nat Biotechnol. 2017 May 9;35(5):426-428
– reference: 28429802 - Nat Rev Neurol. 2017 Jun;13(6):318-319
– reference: 28590561 - Mov Disord. 2017 Jul;32(7):991
SSID ssj0006466
Score 2.6373918
Snippet In vivo reprogramming of astrocytes to dopamine neurons improves motor behavior in a mouse model of Parkinson's disease. Cell replacement therapies for...
Cell replacement therapies for neurodegenerative disease have focused on transplantation of the cell types affected by the pathological process. Here we...
In vivo reprogramming of astrocytes to dopamine neurons improves motor behavior in a mouse model of Parkinson's disease.Cell replacement therapies for...
SourceID swepub
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 444
SubjectTerms 13/106
13/51
14/1
14/19
14/34
14/63
38/39
38/77
38/91
631/378/1687
631/61/490
64/60
Agriculture
Animals
ASCL1 protein
Astrocytes
Astrocytes - cytology
Astrocytes - transplantation
Beta2 protein
Bioinformatics
Biomedical and Life Sciences
Biomedical Engineering/Biotechnology
Biomedicine
Biotechnology
Cell Differentiation - genetics
Cells
Cells, Cultured
Cellular Reprogramming Techniques - methods
Chromatin remodeling
Direct conversion
Dopamine
Dopaminergic Neurons - cytology
Efficiency
Excitability
Fibroblasts
Health aspects
Humans
Infections
Life Sciences
Mesencephalon
Mice
miRNA
Morphology
Movement disorders
Movement Disorders - etiology
Movement Disorders - pathology
Movement Disorders - prevention & control
Neostriatum
Neural circuitry
Neurodegeneration
Neurodegenerative diseases
Neurogenesis
Neurons
Neurosciences
Parkinson disease
Parkinson Disease - complications
Parkinson Disease - pathology
Parkinson Disease - therapy
Parkinson's disease
Physiological aspects
Sample variance
Transcription factors
Treatment Outcome
Wnt protein
Title Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model
URI https://link.springer.com/article/10.1038/nbt.3835
https://www.ncbi.nlm.nih.gov/pubmed/28398344
https://www.proquest.com/docview/1896840885
https://www.proquest.com/docview/3226333520
https://www.proquest.com/docview/1886751360
https://www.proquest.com/docview/1901760874
http://kipublications.ki.se/Default.aspx?queryparsed=id:135777783
Volume 35
WOSCitedRecordID wos000400809800019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 1546-1696
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0006466
  issn: 1087-0156
  databaseCode: M7P
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Engineering Database
  customDbUrl:
  eissn: 1546-1696
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0006466
  issn: 1087-0156
  databaseCode: M7S
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1546-1696
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0006466
  issn: 1087-0156
  databaseCode: 7X7
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1546-1696
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0006466
  issn: 1087-0156
  databaseCode: BENPR
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Research Library
  customDbUrl:
  eissn: 1546-1696
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0006466
  issn: 1087-0156
  databaseCode: M2O
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/pqrl
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 1546-1696
  dateEnd: 20181231
  omitProxy: false
  ssIdentifier: ssj0006466
  issn: 1087-0156
  databaseCode: M2P
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYBgge-ChfhVEZBOtTWD4cfzyhgTbBw7pqA9S3yHGcqRqkY8kmTfzz3DluaMs0IfFitfU1iu3z-c738SPkjQyFyJVNAoshNCzM80BKbQOZ5FymZSxkmjuwCTEayclEjf2FW-3DKucy0QnqYmbwjnwbGI8nmCAUvj_9GSBqFHpXPYTGGtkAzSbCkK79eNxJYt76KqNQYnhlyufFZxO5XeXNOzDO0qXjaFUoL5xKnZt0paSoO4b27v_vAB6Qe14BpTstxzwkN2zVI7daSMrLHrm7UKCwR27ve9f7I_ILQT5cEgSdlRSPw_YWkRZgdv8AEupKY1Y1xYwV6rD_qK4bOCAvQZ2l04peTOEb1VVB8b7BrvRqihnYLhltWFPvOKIOqecx-bq3--Xjp8AjNwQG7K8mYIYrDjwK1lCkeSJ0VLBcl7wIeZ4WsbGhTbnNBfBCJEthy4LHjIe6ZNyaEoTQE7JezSr7jNAwLRTYuLGKI820KXPBUlsqxYwwSkeqT4bzBcyML2uO6BrfM-deT2QGS53hUvfJq47ytC3lcQXNW-SBzCOAQlPjHUl9rM_rOtthCox3ruKwT147OqygUWGITkvw-eDbPxAdHS4RDT1ROYP3NtqnRcDosTLXEuXmEiXIAbPcPee7zMuhOoukwmo-UqZXdv_hSZicrhsfjKF3lQVmgEdIMCqjhF9HA1ql4LDNWJ88bbdMN8WgvyoEc4HZmO-hhff7a_632t3V_R3Ln_ufTuCTzRgo0Al7fv1wXpA7MepfLjJ1k6w3Z-f2JblpLpppfTYga2IiXCsHZOPD7mh8OEDJceDaMbaibY9-AwDQdyc
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxELZKeR94hFeggEGUnJbuw-u1DwhVQNWobahKQb0tXq8XRcBu6G6LIv4Tv5EZ74MkVBWXHrhESTyxvJOZ8Yw9Mx8hz4QbRYk0gWMwhYa5SeIIoYwjgoSLMPMjESYWbCIajcTBgdxdIr_aWhhMq2xtojXUaaHxjHwNBI8HWCDkvpp8dxA1Cm9XWwiNWiy2zPQHhGzly-Eb-H9XfX_j7f7rTadBFXA0xAaVwzSXHPgHnrqneBApL2WJynjq8iRMfW1cE3KTRLBOT2SRyVLuM-6qjHGjM1AQmPccOc-wsximCvq7neXn9d2o5wpM5wx52-w2EGt5Ur2AYDCc2_4WN4GZXbC7ll1oYWq3vY3r_xvDbpBrjYNN12uNuEmWTN4jF2vIzWmPXJ1pwNgjl3aa1IJb5CeCmNgiD1pkFLf7-pSUpsVEfQMSalt_5iXFihxqsQ2pKitwAKbgrtNxTo_H8ImqPKV4nmIWRhXFCnNbbDcoaXMxRi0S0W3y4UxYcocs50Vu7hHqhqmEGN6XvqeY0lkSsdBkUjIdaak82SeDVmBi3bRtR_SQr7FNHwhEDKIVo2j1yZOOclK3KjmBZhVlLm4QTuGlxDOg8rM6Kst4nUkP3Hnpu33y1NJhh5AcU5BqguG7j_9A9H5vjmjQEGUFrFurpuwDnh47j81RrsxRgp3T88OtnMeNnS1jT0jsViREeOLwHx0A5nTDODGmFuYGhAGmEBA0ewE_jQa85oiDWrM-uVuraMdi8M8lgtUAN1qdnVnfX_x_Xmtz93Ns79589QXemZhBgBCw-6c_zmNyeXN_ZzveHo62HpArPvqaNgt3hSxXh0fmIbmgj6txefjIWihKPp21hv8GW7nP2g
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxELZKChUceIRXoIBBlJyW7MPrtQ8IFdqIqBCi8lBvi9frRRGwCd20KOKf8euY2fUuSagqLj1wiZL4i-WdzHhm7HkQ8li4UZRIEzgGQ2iYmySOEMo4Iki4CDM_EmFSNpuIhkNxcCBHa-RXnQuDYZX1nlhu1OlE4xl5DxiPB5gg5PYyGxYx2uk_n353sIMU3rTW7TQqFtkz8x_gvhXPBjvwX2_5fn_3_ctXju0w4GjwE2YO01xyoCVY7Z7iQaS8lCUq46nLkzD1tXFNyE0SwZo9kUUmS7nPuKsyxo3OQFhg3nNkPQIjg7XI-ovd4Wi_0QO8uin1XIHBnSGvS98Gopcns6fgGoZLynBVJSzoxOaSdqWgaakE-1f-Z_JdJZet6U23K1m5RtZM3iYXqmac8za5tFCasU023tigg-vkJ7Y3KdM_6CSjaAhU56c0nUzVN4DQsihoXlDM1aFl10OqihmYBnMw5Ok4p8dj-ERVnlI8aTEro4pi7nmZhtctqL0yo2WPohvkw5mQ5CZp5ZPc3CbUDVMJ3r0vfU8xpbMkYqHJpGQ60lJ5skO6NfPE2hZ0x74iX-MysCAQMbBZjGzWIQ8b5LQqYnICZgv5L7a9T-GlwNOh4rM6Kop4m0kPDH3pux3yqMRh7ZAc2agCDN5-_AfQu_0lUNeCsgmsWyubEAJPjzXJlpCbS0jYAfXycM3zsd2Bi9gTEusYCRGeOPxHHoA4zTBOjEGHuQFmgCkEuNNewE_DgD0dcRBx1iG3KnFtSAyWu8Q2NkCNWn4X1vcX_Z9Ukt38HAu_26--wDsTM3AdAnbn9Md5QDZAsOPXg-HeXXLRRyO0DM_dJK3Z4ZG5R87r49m4OLxvtytKPp21iP8GuN_Z9A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Induction+of+functional+dopamine+neurons+from+human+astrocytes+in+vitro+and+mouse+astrocytes+in+a+Parkinson%27s+disease+model&rft.jtitle=Nature+biotechnology&rft.au=Rivetti+di+Val+Cervo%2C+Pia&rft.au=Romanov%2C+Roman+A&rft.au=Spigolon%2C+Giada&rft.au=Masini%2C+D%C3%A9bora&rft.date=2017-05-01&rft.pub=Nature+Publishing+Group&rft.issn=1087-0156&rft.volume=35&rft.issue=5&rft.spage=444&rft_id=info:doi/10.1038%2Fnbt.3835&rft.externalDocID=A491326920
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1087-0156&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1087-0156&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1087-0156&client=summon